BPC-157 has been found to counteract side effects of NSAIDs, medications used in psychiatric conditions, and a number of heart medications
By enhancing oxygen transport, it promotes greater energy and vitality
Related Research Compounds BPC-157 10mg Individual BPC-157 research compound TB-500 10mg Individual TB-500 research compound KLOW 80mg Multi-peptide high-dose research blend including BPC-157 and TB-500 For laboratory and in-vitro research use only
Zhang and Nuss, 2016)
Baseline inflammatory markers (CRP, ESR, IL-6 if available), imaging of known endometriotic lesions, a bone density scan if you have had prior GnRH agonist use, and metabolic parameters provide objective data to track whether the medication is producing measurable changes
If no problems occur, gradually increase to your target dose